These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3159026)

  • 1. Inhibition of metabolism of the 'nonclassical' antifolate, trimetrexate (2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline) by drugs containing an imidazole moiety.
    Heusner JJ; Franklin MR
    Pharmacology; 1985; 30(5):266-72. PubMed ID: 3159026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro.
    Kamen BA; Eibl B; Cashmore A; Bertino J
    Biochem Pharmacol; 1984 May; 33(10):1697-9. PubMed ID: 6233981
    [No Abstract]   [Full Text] [Related]  

  • 3. 2,4-Diamino-5-chloroquinazoline analogues of trimetrexate and piritrexim: synthesis and antifolate activity.
    Rosowsky A; Mota CE; Wright JE; Queener SF
    J Med Chem; 1994 Dec; 37(26):4522-8. PubMed ID: 7799402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational analysis of antineoplastic antifolates: the crystal structure of trimetrexate and the aminopterine derivative 4-[N-[(2,4-diamino-6-pteridinyl)methyl]amino]benzoic acid.
    Sutton PA; Cody V
    J Med Chem; 1987 Oct; 30(10):1843-8. PubMed ID: 2958629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic assays for 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, a promising new "nonclassical" antifolate.
    Heusner JJ; McCormack JJ
    J Pharm Sci; 1981 Jul; 70(7):827-8. PubMed ID: 6455513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and toxicity of a potent "nonclassical" 2,4-diamino quinazoline folate antagonist, trimetrexate, in normal dogs.
    Weir EC; Cashmore AR; Dreyer RN; Graham ML; Hsiao N; Moroson BA; Sawicki WL; Bertino JR
    Cancer Res; 1982 May; 42(5):1696-702. PubMed ID: 6461409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucovorin antagonizes the effects of trimetrexate on mouse hemopoietic progenitors.
    Lerza R; Mencoboni M; Bogliolo G; Flego G; Gasparini L; Pannacciulli I
    Anticancer Res; 1991; 11(2):613-6. PubMed ID: 1829599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics.
    Pasanen M; Taskinen T; Iscan M; Sotaniemi EA; Kairaluoma M; Pelkonen O
    Biochem Pharmacol; 1988 Oct; 37(20):3861-6. PubMed ID: 3263862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog.
    Wong BK; Woolf TF; Chang T; Whitfield LR
    Drug Metab Dispos; 1990; 18(6):980-6. PubMed ID: 1981548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of antithrombitic and antimycotic N-substituted imidazoles on rat hepatic microsomal steroid and xenobiotic hydroxylases in vitro.
    Murray M; Zaluzny L
    Biochem Pharmacol; 1988 Feb; 37(3):415-20. PubMed ID: 3337742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of the histamine H2-receptor antagonist etintidine with rat liver cytochrome P-450: a comparison with cimetidine.
    Schulz M; Schmoldt A
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):453-8. PubMed ID: 2893298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of nonclassical 2,4-diamino-5-methylpyrido[2,3-d]pyrimidines with novel side chain substituents as potential inhibitors of dihydrofolate reductases.
    Gangjee A; Vasudevan A; Queener SF
    J Med Chem; 1997 Feb; 40(4):479-85. PubMed ID: 9046338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and inhibition of rat hepatic drug metabolism by N-substituted imidazole drugs.
    Ritter JK; Franklin MR
    Drug Metab Dispos; 1987; 15(3):335-43. PubMed ID: 2886308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor--I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo.
    Bertino JR; Sawicki WL; Moroson BA; Cashmore AR; Elslager EF
    Biochem Pharmacol; 1979 Jun; 28(12):1983-7. PubMed ID: 454469
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
    J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimetrexate: molecular structures and conformational similarities in two crystal forms.
    Hempel A; Camerman N; Camerman A
    Cancer Biochem Biophys; 1988 Jul; 10(1):25-30. PubMed ID: 2975964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and biliary excretion of trimetrexate by the isolated perfused rat liver.
    Webster LK; Tong WP; McCormack JJ
    Cancer Lett; 1985 Oct; 29(1):65-71. PubMed ID: 2933139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methotrexate and of the "nonclassical" folate antagonist trimetrexate on human leukemia cells.
    Rodenhuis S; McGuire JJ; Sawicki WL; Bertino JR
    Leukemia; 1987 Feb; 1(2):116-20. PubMed ID: 2959824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects on the immune system of methotrexate and trimetrexate.
    Rosenthal GJ; Germolec DR; Lamm KR; Ackermann MF; Luster MI
    Int J Immunopharmacol; 1987; 9(7):793-801. PubMed ID: 2962953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.